The primary risk factors for stroke in PV patients are age, JAK2 exon V617F mutation (JAK2/V617F), as well as previous history of thrombosis, and early diagnosis can improve the management and clinical outcomes of patients. This evidence concerns the gene JAK2 and Venous thrombosis.